|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 19.26 USD | +0.63% |
|
-1.33% | +42.77% |
| 08-25 | Escalade, Incorporated acquired Assets of ASL Solutions from ASL Solutions. | CI |
| 08-25 | Escalade Buys Insulated Pet House Maker ASL Assets | MT |
| Fiscal Period: December | 2016 (USD) | 2017 (USD) | 2018 (USD) | 2019 (USD) | 2020 (USD) | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.44 | 5.98 | 4.04 | 4.2 | 5.22 | |||||
Return on Total Capital | 10.57 | 7.01 | 4.57 | 4.79 | 6.02 | |||||
Return On Equity % | 17.08 | 11.79 | 6.08 | 7.79 | 8.01 | |||||
Return on Common Equity | 17.08 | 11.79 | 6.08 | 7.79 | 8.01 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.59 | 23.47 | 23.44 | 24.73 | 26.92 | |||||
SG&A Margin | 13.83 | 14.27 | 15.74 | 17.22 | 18.17 | |||||
EBITDA Margin % | 11.71 | 10.32 | 8.91 | 8.8 | 9.91 | |||||
EBITA Margin % | 10.77 | 9.2 | 7.7 | 7.52 | 8.76 | |||||
EBIT Margin % | 10.17 | 8.39 | 6.76 | 6.4 | 7.8 | |||||
Income From Continuing Operations Margin % | 7.78 | 5.73 | 3.73 | 5.16 | 5.7 | |||||
Net Income Margin % | 7.78 | 5.73 | 3.73 | 5.16 | 5.7 | |||||
Net Avail. For Common Margin % | 7.78 | 5.73 | 3.73 | 5.16 | 5.7 | |||||
Normalized Net Income Margin | 6.09 | 4.5 | 2.96 | 3.45 | 4.69 | |||||
Levered Free Cash Flow Margin | -4.7 | -2.22 | 17.27 | 13.35 | 9.36 | |||||
Unlevered Free Cash Flow Margin | -4.4 | -1.47 | 18.54 | 13.92 | 9.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.33 | 1.14 | 0.96 | 1.05 | 1.07 | |||||
Fixed Assets Turnover | 13.35 | 10.29 | 7.99 | 9.05 | 10.21 | |||||
Receivables Turnover (Average Receivables) | 4.78 | 5.08 | 4.91 | 5.09 | 5.05 | |||||
Inventory Turnover (Average Inventory) | 2.87 | 2.24 | 1.88 | 2.25 | 2.43 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.55 | 4.83 | 4.41 | 3.88 | 4.28 | |||||
Quick Ratio | 1.46 | 1.58 | 1.5 | 1.54 | 1.91 | |||||
Operating Cash Flow to Current Liabilities | 0.02 | 0.22 | 1.45 | 1.05 | 1.02 | |||||
Days Sales Outstanding (Average Receivables) | 76.18 | 72.96 | 74.37 | 71.85 | 72.26 | |||||
Days Outstanding Inventory (Average Inventory) | 126.89 | 165.52 | 193.84 | 162.87 | 150.25 | |||||
Average Days Payable Outstanding | 26.12 | 17.38 | 20.34 | 22.92 | 22.83 | |||||
Cash Conversion Cycle (Average Days) | 176.95 | 221.1 | 247.87 | 211.8 | 199.68 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 40.75 | 65.95 | 36.36 | 15.87 | 11.41 | |||||
Total Debt / Total Capital | 28.95 | 39.74 | 26.66 | 13.7 | 10.24 | |||||
LT Debt/Equity | 35.32 | 60.82 | 31.38 | 11.38 | 6.99 | |||||
Long-Term Debt / Total Capital | 25.09 | 36.65 | 23.02 | 9.82 | 6.27 | |||||
Total Liabilities / Total Assets | 41.77 | 46.95 | 34.95 | 25.33 | 22.01 | |||||
EBIT / Interest Expense | 21.12 | 6.96 | 3.33 | 6.99 | 22.4 | |||||
EBITDA / Interest Expense | 27.56 | 9.77 | 5.13 | 10.96 | 30.61 | |||||
(EBITDA - Capex) / Interest Expense | 21.14 | 9.22 | 4.74 | 10.08 | 27.61 | |||||
Total Debt / EBITDA | 1.44 | 2.83 | 2.18 | 1.06 | 0.77 | |||||
Net Debt / EBITDA | 1.33 | 2.72 | 2.18 | 0.9 | 0.31 | |||||
Total Debt / (EBITDA - Capex) | 1.87 | 3 | 2.36 | 1.16 | 0.86 | |||||
Net Debt / (EBITDA - Capex) | 1.73 | 2.89 | 2.36 | 0.98 | 0.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.6 | 0.05 | -16 | -4.57 | -4.51 | |||||
Gross Profit, 1 Yr. Growth % | 3.08 | -4.53 | -16.12 | 0.7 | 3.92 | |||||
EBITDA, 1 Yr. Growth % | -0.86 | -11.85 | -27.48 | -5.72 | 7.45 | |||||
EBITA, 1 Yr. Growth % | -2.17 | -14.48 | -29.73 | -6.85 | 11.26 | |||||
EBIT, 1 Yr. Growth % | -3.44 | -17.5 | -32.32 | -9.61 | 16.32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -5.9 | -26.29 | -45.36 | 32.12 | 5.51 | |||||
Net Income, 1 Yr. Growth % | -5.9 | -26.29 | -45.36 | 32.12 | 5.51 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.21 | -25.97 | -44.76 | 11.03 | 29.93 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -3.3 | -25.57 | -45.8 | 30.99 | 6.45 | |||||
Accounts Receivable, 1 Yr. Growth % | 1.09 | -12.99 | -12.95 | -2.43 | -5.03 | |||||
Inventory, 1 Yr. Growth % | 27.44 | 31.92 | -24.13 | -17.78 | -9.93 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 36.82 | 24.7 | -4.98 | -27.23 | 0.96 | |||||
Total Assets, 1 Yr. Growth % | 14.09 | 18.63 | -15.3 | -10.54 | -1.86 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.13 | -8.71 | 10.1 | 7.71 | 4.57 | |||||
Common Equity, 1 Yr. Growth % | 5.36 | 8.09 | 3.85 | 2.68 | 2.5 | |||||
Cash From Operations, 1 Yr. Growth % | -64.34 | 807.77 | 463.59 | -25.41 | -13.97 | |||||
Capital Expenditures, 1 Yr. Growth % | 77.75 | -78.23 | -1.23 | -2.25 | 23.26 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 13.13 | -52.74 | -758.23 | -26.25 | -33.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 7.18 | -66.63 | -1.17K | -28.35 | -34.29 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.66 | 7.14 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 31.8 | 7.08 | -8.33 | -10.47 | -4.54 | |||||
Gross Profit, 2 Yr. CAGR % | 34.94 | -0.8 | -10.51 | -8.09 | 2.3 | |||||
EBITDA, 2 Yr. CAGR % | 66.15 | -6.51 | -20.04 | -17.31 | 0.65 | |||||
EBITA, 2 Yr. CAGR % | 77.27 | -8.53 | -22.48 | -19.09 | 1.8 | |||||
EBIT, 2 Yr. CAGR % | 85.44 | -10.74 | -25.27 | -21.78 | 2.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 83.37 | -16.71 | -36.54 | -15.04 | 18.07 | |||||
Net Income, 2 Yr. CAGR % | 83.37 | -16.71 | -36.54 | -15.04 | 18.07 | |||||
Normalized Net Income, 2 Yr. CAGR % | 84.92 | -17.12 | -36.05 | -21.68 | 20.11 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 87.62 | -15.16 | -36.49 | -15.74 | 18.08 | |||||
Accounts Receivable, 2 Yr. CAGR % | 36.44 | -6.21 | -12.97 | -7.84 | -3.74 | |||||
Inventory, 2 Yr. CAGR % | 47.84 | 29.66 | 0.04 | -21.02 | -13.94 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 29.48 | 30.62 | 8.85 | -16.85 | -14.29 | |||||
Total Assets, 2 Yr. CAGR % | 30.09 | 16.34 | 0.24 | -12.96 | -6.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | 7.52 | 0.72 | 0.25 | 8.9 | 6.13 | |||||
Common Equity, 2 Yr. CAGR % | 7.8 | 6.72 | 5.95 | 3.27 | 2.59 | |||||
Cash From Operations, 2 Yr. CAGR % | -75.8 | 79.93 | 570.81 | 105.04 | -19.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | 110.65 | -37.79 | -53.63 | -1.74 | 9.76 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.78 | -26.88 | 76.53 | 120.33 | -29.72 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 3.37 | -40.2 | 89.11 | 177.29 | -31.39 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.83 | 6.4 | 3.51 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 21.29 | 20.23 | -1.24 | -7.09 | -8.53 | |||||
Gross Profit, 3 Yr. CAGR % | 19.65 | 20.24 | -6.19 | -6.92 | -4.25 | |||||
EBITDA, 3 Yr. CAGR % | 27.61 | 34.5 | -14.1 | -15.53 | -9.76 | |||||
EBITA, 3 Yr. CAGR % | 30.41 | 39.03 | -16.23 | -17.58 | -10.03 | |||||
EBIT, 3 Yr. CAGR % | 32.16 | 41.57 | -18.61 | -20.38 | -10.72 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.08 | 35.33 | -27.63 | -18.97 | -8.68 | |||||
Net Income, 3 Yr. CAGR % | 6.08 | 35.33 | -27.63 | -18.97 | -8.68 | |||||
Normalized Net Income, 3 Yr. CAGR % | 31.54 | 36.28 | -27.6 | -23.14 | -7.29 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.67 | 37.86 | -26.93 | -19.15 | -8.91 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.5 | 17.44 | -8.51 | -9.59 | -6.91 | |||||
Inventory, 3 Yr. CAGR % | 33.16 | 42.33 | 8.45 | -6.29 | -17.48 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 20.54 | 27.87 | 17.47 | -4.82 | -11.29 | |||||
Total Assets, 3 Yr. CAGR % | 18.97 | 26.16 | 4.66 | -3.49 | -9.41 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.27 | 1.81 | 3.75 | 2.68 | 7.44 | |||||
Common Equity, 3 Yr. CAGR % | 4.54 | 7.9 | 5.75 | 4.85 | 3.01 | |||||
Cash From Operations, 3 Yr. CAGR % | -47.55 | -19 | 163.78 | 222.57 | 53.5 | |||||
Capital Expenditures, 3 Yr. CAGR % | 50.97 | -1.14 | -27.43 | -40.54 | 5.97 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 92.34 | -18.12 | 51.73 | 31.97 | 48.14 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 80.7 | -29.09 | 55.99 | 36.84 | 71.59 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.85 | 6.27 | 4.22 | 2.33 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.81 | 12.09 | 8.44 | 6.86 | -2.58 | |||||
Gross Profit, 5 Yr. CAGR % | 11.75 | 10.49 | 6.53 | 7.99 | -2.88 | |||||
EBITDA, 5 Yr. CAGR % | 13.12 | 11.83 | 5.85 | 10.72 | -8.48 | |||||
EBITA, 5 Yr. CAGR % | 14.83 | 12.28 | 5.92 | 11.96 | -9.43 | |||||
EBIT, 5 Yr. CAGR % | 16.94 | 12.5 | 5.21 | 11.66 | -10.73 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.25 | 5.05 | -13.62 | 12.34 | -11.98 | |||||
Net Income, 5 Yr. CAGR % | 16.25 | 5.05 | -13.62 | 12.34 | -11.98 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.47 | 8.18 | -1.42 | 9.2 | -11.35 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 17.08 | 5.98 | -12.82 | 13.21 | -11.47 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.95 | 7.85 | 4.2 | 6.59 | -6.63 | |||||
Inventory, 5 Yr. CAGR % | 22.27 | 28.22 | 18.77 | 12.46 | -1.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 14.63 | 18.83 | 15.72 | 7.65 | 3.56 | |||||
Total Assets, 5 Yr. CAGR % | 10.8 | 13.86 | 11.09 | 8.75 | 0.13 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.41 | 3.84 | 2.65 | 4.59 | 4.7 | |||||
Common Equity, 5 Yr. CAGR % | 7.59 | 7.25 | 5.1 | 6.02 | 4.48 | |||||
Cash From Operations, 5 Yr. CAGR % | -40.09 | -8.6 | 49.34 | 17.58 | 63.77 | |||||
Capital Expenditures, 5 Yr. CAGR % | 29.59 | -5.12 | -5.85 | -1.38 | -14.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.41 | -1.08 | 85.51 | 21.48 | 11.52 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.58 | -10.14 | 83.66 | 22.08 | 12.31 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.94 | 5.46 | 3.71 | 3.71 | 2.51 |
- Stock Market
- Stocks
- ESCA Stock
- Financials Escalade, Incorporated
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















